Buchumschlag

Site-Level Distribution Shift Dominates Disease Signal and Undermines Cross-Site Generalization in High-Dimensional Microbiome Classifiers

Fuente: Zenodo

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Pereira, Antonio
Format:	Recurso digital
Veröffentlicht:	Zenodo 2026
Schlagworte:	distribution shift cross-site validation biomedical machine learning Parkinson Disease generalization compositional data analysis
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Reproducible Analysis of Cross-Site Distribution Shift in High-Dimensional Microbiome Classifiers
von: Pereira, Antonio
Veröffentlicht: (2026)

Website Phishing Detector
von: Mrs Varshini J, et al.
Veröffentlicht: (2025)

Exploratory data analysis in the context of data mining and resampling.
von: Chong Ho Yu
Veröffentlicht: (2010)

PARAMETER SELECTION IN LEAST SQUARES-SUPPORT VECTOR MACHINES REGRESSION ORIENTED, USING GENERALIZED CROSS-VALIDATION
von: ANDRÉS M. ÁLVAREZ MEZA
Veröffentlicht: (2012)

Bifactorial Structure of Locus of Control Cross-culturally Invariant across Spain, Chile and United Kingdom
von: Javier Suárez-Álvarez
Veröffentlicht: (2015)

Serum GDF‐15 Levels Correlate With Motor and Nonmotor Symptom Domains and Overall Disease Severity in Patients With Parkinson’s Disease
von: Noriyuki Miyaue, et al.
Veröffentlicht: (2026)

ICF‐Based Assessment of Functioning Problems in Parkinson’s Disease: Findings From a Cross‐Sectional Survey in Southern Ghana
von: Mary Wetani Agoriwo, et al.
Veröffentlicht: (2026)

Identification of Gene Signatures and Molecular Mechanisms for Diagnosing Parkinson’s Disease and Nonalcoholic Fatty Liver Disease Using Machine Learning
von: Xuan Chen, et al.
Veröffentlicht: (2026)

A Cognitive‐Behavioral Model of Apathy in Parkinson’s Disease
von: Olivia Plant, et al.
Veröffentlicht: (2024)

Trait Impulsivity as a Feature of Parkinson’s Disease Treatment and Progression
von: Holly Spencer, et al.
Veröffentlicht: (2024)

Determining Medication Adherence in Patients Treated for Parkinson’s Disease and Related Factors
von: Mahboobeh Besharatpour, et al.
Veröffentlicht: (2025)

Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease
von: Chatkaew Pongmala, et al.
Veröffentlicht: (2024)

Cystatin C Secretion in Blood Derivatives and Cellular Models of Idiopathic Parkinson’s Disease
von: Kathleen Mommaerts, et al.
Veröffentlicht: (2025)

Mucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials
von: Fatima Hammoud, et al.
Veröffentlicht: (2025)

Daily Fluid Intake in People With Newly Diagnosed Parkinson’s Disease Is Reduced Compared With Controls
von: Isobel J. Sleeman, et al.
Veröffentlicht: (2025)

Views and Experiences of Online Exercise Groups for People With Parkinson’s Disease: A Qualitative Study
von: James Alexander, et al.
Veröffentlicht: (2026)

Improvement by Medication Less than Expected in Parkinson’s Disease: Blinded Evaluation of Levodopa Response
von: Mette Niemann Johansen, et al.
Veröffentlicht: (2024)

Mental Fatigue in Parkinson’s Disease: Systematic Review and Evaluation of Self‐Reported Fatigue Scales
von: Junle Chen, et al.
Veröffentlicht: (2024)

Possible Implications of Managing Alexithymia on Quality of Life in Parkinson’s Disease: A Systematic Review
von: Laura Culicetto, et al.
Veröffentlicht: (2024)

Research Participation Among American Indian and Alaskan Native Individuals Living With Parkinson’s Disease
von: Jacob D. Jones, et al.
Veröffentlicht: (2025)

Urban Wind Energy Assessment Using Machine Learning and Multi-criteria Analysis
von: Gianina Garrido-Silva
Veröffentlicht: (2025)

Towards a Biologically Defined Diagnosis: Incorporating Pathophysiological Measures Into Parkinson’s Disease Clinical Criteria
von: Angus McNamara, et al.
Veröffentlicht: (2026)

Factors Influencing Pain Management Practices in People With Parkinson’s Disease: A Qualitative Descriptive Study
von: Anthony Mezzini, et al.
Veröffentlicht: (2025)

A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson’s Disease
von: Pauli Seppänen, et al.
Veröffentlicht: (2024)

Oxidative Stress: A New Pathophysiological Pathway in Parkinson’s Disease and a Potential Target of the Brain‐Sport Crosstalk
von: Stefano Caproni, et al.
Veröffentlicht: (2025)

Clove Essential Oil Enhances Antioxidant Defenses and Reduces DNA Damage in a Cellular Model of Parkinson’s Disease
von: Dhouha Hamdi, et al.
Veröffentlicht: (2025)

Changes in Visual Evoked Potential and Optical Coherence Tomography in Parkinson’s Disease: A Systematic Review and Meta‐Analysis
von: Zahra Hemmatian, et al.
Veröffentlicht: (2025)

Genome‐Wide Association Studies Data and Transcriptomics Data Link Herpes Simplex Virus 1 Infection and Parkinson’s Disease
von: Changhao Lu, et al.
Veröffentlicht: (2025)

Predictive Value of Brain Volumetry in the Response to Subthalamotomy Using High‐Intensity Focused Ultrasound Treatment in Patients With Parkinson’s Disease
von: Alfaro-Nasta E., et al.
Veröffentlicht: (2025)

Patient‐Reported Outcomes of Rotigotine in Parkinson’s Disease: Real‐World Evidence on Symptom Control and Quality of Life From China
von: Xiaodong Zhu, et al.
Veröffentlicht: (2025)

Construction and Identification of Inflammation‐Related TF–mRNA–miRNA Coexpression Network and Immune Infiltration in Parkinson’s Disease
von: Zhuzhen Shen, et al.
Veröffentlicht: (2025)

The Use of a Digital Social Forum in a Parkinson’s Disease Risk Cohort: A Thematic Analysis of Forum Messages
von: Laura J. Smith, et al.
Veröffentlicht: (2026)

Method of Tremor Levodopa Responsiveness Assessment and Its Correlation With Clinical Factors in Parkinson’s Disease: Outcomes of the Acute Levodopa Challenge Test
von: Fangfei Li, et al.
Veröffentlicht: (2025)

Diagnostic Accuracy of Machine Learning‐Assisted MRI for Mild Cognitive Impairment in Parkinson’s Disease: A Systematic Review and Meta‐Analysis
von: Feng Zhang, et al.
Veröffentlicht: (2025)

Abwanderung nach Gehaltsverhandlung /
von: Marvin Hinske
Veröffentlicht: (2025)

Cinnamaldehyde Attenuates the Expression of IBA1 and GFAP to Inhibit Glial Cell Activation and Inflammation in the MPTP‐Induced Acute Parkinson’s Disease Model
von: Panpan Jiao, et al.
Veröffentlicht: (2024)

Preoperative Attention/Memory Problem Affects the Quality of Life of Parkinson’s Disease Patients after Deep Brain Stimulation: A Cohort Study
von: Ying Gao, et al.
Veröffentlicht: (2024)

The Priority Goals and Underlying Impairments Contributing to Goal-Related Problems of People with Parkinson’s Disease Receiving a Community-Based Rehabilitation Program
von: Sarah J. Davies, et al.
Veröffentlicht: (2024)

China’s Modified Version of Sniffin’ Sticks 12‐Identification Test Used in Chinese Parkinson’s Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods
von: Huijing Liu, et al.
Veröffentlicht: (2024)

EMPOWER‐PD: Evaluation of an 8‐Week Co‐Designed Self‐Management Program in People With Parkinson’s Disease and Their Caregivers: An Intervention Study With Long‐Term Follow‐Up
von: Trine Hørmann Thomsen, et al.
Veröffentlicht: (2025)